Q97911589

Summary

Q97911589 is a committee group motion^[1].

Key Facts

• Q97911589 authored Erik Ullenhag^[2].
• Q97911589 authored Kerstin Heinemann^[3].
• Q97911589 authored Marita Aronson^[4].
• Q97911589 authored Gabriel Romanus^[5].
• Q97911589 authored Mia Franzén^[6].
• Q97911589 authored Linnéa Darell^[7].
• Q97911589's instance of is recorded as committee group motion^[8].
• Q97911589's part of the series is recorded as motions of the 2005-2006 legislative session of the Riksdag^[9].
• Q97911589's language of work or name is recorded as Swedish^[10].
• Q97911589 was published on +2005-10-05T00:00:00Z^[11].
• Q97911589's main subject is medication^[12].
• Q97911589's work available at URL is recorded as http://data.riksdagen.se/dokument/GT02So673^[13].
• Q97911589's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GT02So673^[14].
• Q97911589's applies to jurisdiction is recorded as Sweden^[15].
• Q97911589's legal citation of this text is recorded as Mot. 2005/06:So673^[16].
• Q97911589's title is recorded as Säker läkemedelsinformation^[17].
• Q97911589's cites work is recorded as Q98138519^[18].
• Q97911589's maintained by WikiProject is recorded as Project Riksdagen's documents^[19].
• Q97911589's copyright status is recorded as public domain^[20].
• Q97911589's legislative committee is recorded as Committee on Health and Welfare^[21].

Body

Definition and Type

Q97911589's instance of is recorded as committee group motion^[8].